| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008015511 |
| P356 | DOI | 10.1007/S10334-005-0111-Y |
| P698 | PubMed publication ID | 16155762 |
| P5875 | ResearchGate publication ID | 7606592 |
| P50 | author | Pieter C.M.M. Magusin | Q58481878 |
| Willem J.M. Mulder | Q62656505 | ||
| Klaas Nicolay | Q38360372 | ||
| Ruud B Van Heeswijk | Q42754852 | ||
| P2093 | author name string | G J Strijkers | |
| P Bomans | |||
| P M Frederik | |||
| P2860 | cites work | A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. | Q51643528 |
| Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma | Q58619128 | ||
| Molecular Imaging | Q22065366 | ||
| Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications | Q28212229 | ||
| Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. | Q33784378 | ||
| Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
| Liposomes: From the Bench to the Bed | Q35119261 | ||
| Can receptors be imaged with MRI agents? | Q41514984 | ||
| Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo | Q42042312 | ||
| Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity | Q43919780 | ||
| Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging | Q46789795 | ||
| The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates | Q47407264 | ||
| Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. | Q47990066 | ||
| P433 | issue | 4 | |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| contrast agent | Q6849688 | ||
| P304 | page(s) | 186-192 | |
| P577 | publication date | 2005-09-09 | |
| P1433 | published in | Magnetic Resonance Materials in Physics, Biology and Medicine | Q15763882 |
| P1476 | title | Relaxivity of liposomal paramagnetic MRI contrast agents | |
| P478 | volume | 18 |
| Q36625800 | (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer |
| Q48229419 | A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection |
| Q36483514 | Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits |
| Q30317580 | Benchtop MRI for pharmacokinetic evaluation of two aqueous-based nano-scaled formulations of oleic acid stabilized magnetite nanocrystals |
| Q30859122 | Characterization of a lanthanide complex encapsulated with MRI contrast agents into liposomes for biosensor imaging of redundant deviation in shifts (BIRDS). |
| Q34378765 | Chelating DTPA amphiphiles: ion-tunable self-assembly structures and gadolinium complexes. |
| Q33364763 | Cobalt nanoparticles as a novel magnetic resonance contrast agent--relaxivities at 1.5 and 3 Tesla |
| Q35805404 | Compartmentalization of Gd liposomes: the quenching effect explained. |
| Q41268340 | Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids |
| Q30659328 | Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd₂O₃-DEG for molecular MRI. |
| Q30715520 | Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications |
| Q57185272 | Dynamic changes in 1H-MR relaxometric properties of cell-internalized paramagnetic liposomes, as studied over a five-day period |
| Q38138098 | Environmentally responsive MRI contrast agents |
| Q35488256 | Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. |
| Q45891131 | Gadolinium- and manganite-based contrast agents with fluorescent probes for both magnetic resonance and fluorescence imaging of pancreatic islets: a comparative study |
| Q52964266 | Gadolinium-Loaded Polychelating Polymer-Containing Tumor-Targeted Liposomes. |
| Q41196370 | Gd(III)-induced Supramolecular Hydrogelation with Enhanced Magnetic Resonance Performance for Enzyme Detection. |
| Q30993842 | Gd-DTPA-Dopamine-Bisphytanyl Amphiphile: Synthesis, Characterisation and Relaxation Parameters of the Nanoassemblies and Their Potential as MRI Contrast Agents. |
| Q34145477 | Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast |
| Q39217789 | In vivo quantitative assessment of cell viability of gadolinium or iron-labeled cells using MRI and bioluminescence imaging. |
| Q37837837 | In vivo small animal imaging: current status and future prospects |
| Q36460517 | Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging |
| Q36393668 | Interaction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance Imaging |
| Q39289397 | Internalization of paramagnetic phosphatidylserine-containing liposomes by macrophages |
| Q30712193 | MRI stem cell tracking for therapy in experimental cerebral ischemia |
| Q30729090 | Micellar self-assemblies of gadolinium(III)/europium(III) amphiphilic complexes as model contrast agents for bimodal imaging |
| Q40254481 | Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells |
| Q36918008 | Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles |
| Q28082690 | Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents |
| Q42149450 | Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging |
| Q35852930 | New method for site-specific modification of liposomes with proteins using sortase A-mediated transpeptidation |
| Q39061816 | Non-invasive magnetic resonance imaging follow-up of sono-sensitive liposome tumor delivery and controlled release after high-intensity focused ultrasound. |
| Q37730633 | Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. |
| Q37755998 | Paramagnetic liposome nanoparticles for cellular and tumour imaging. |
| Q34736942 | Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. |
| Q34529414 | Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury |
| Q58479805 | Preparation and Evaluation of Multiple Nanoemulsions Containing Gadolinium (III) Chelate as a Potential Magnetic Resonance Imaging (MRI) Contrast Agent |
| Q31160257 | Rational design of protein-based MRI contrast agents |
| Q26744835 | Recent Developments of Liposomes as Nanocarriers for Theranostic Applications |
| Q31153232 | Relaxivities of paramagnetic liposomes: on the importance of the chain type and the length of the amphiphilic complex |
| Q50623896 | Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging. |
| Q24657256 | Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential |
| Q53131221 | Stealth rare earth oxide nanodiscs for magnetic resonance imaging. |
| Q35317271 | Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers |
| Q39328028 | Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent |
| Q34092267 | The Gd3+ complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(p-isothiocyanatoanilide) conjugated to inulin: a potential stable macromolecular contrast agent for MRI. |
| Q35148900 | Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI. |
| Q31132745 | Use of a genetically engineered protein for the design of a multivalent MRI contrast agent |
Search more.